Immunocore
IMCR
132 hedge funds and large institutions have $1.79B invested in Immunocore in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 48 reducing their positions, and 18 closing their positions.
19% more capital invested
Capital invested by funds: $1.5B → $1.79B (+$288M)
2.53% more ownership
Funds ownership: 95.08% → 97.61% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 18
1% less funds holding
Funds holding: 133 → 132 (-1)
15% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 48
81% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $63M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$33.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.3M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$18.7M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$12.1M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$9.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.8M |
| 2 |
Citigroup
New York
|
-$13.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.67M |
| 4 |
Two Sigma Investments
New York
|
-$7.22M |
| 5 |
Two Sigma Advisers
New York
|
-$6.2M |
IMCR Hedge Fund Activity: Q3 2025 in Review
132 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q3 2025, worth a combined $1.79B — up 19% from $1.5B a quarter earlier.
Fund positioning in IMCR was balanced in Q3 2025: 18 funds opened new positions, 18 closed out, 41 added to existing stakes and 48 trimmed.
The largest buyer was Millennium Management, adding an estimated $33.6M. The largest seller was Fidelity Investments, cutting an estimated $14.8M.
- 132 institutional investors held Immunocore (IMCR) as of Q3 2025, down from 133 in Q2 2025.
- Funds reported $1.79B of Immunocore stock for Q3 2025, up 19% quarter-over-quarter.
- 18 funds opened new Immunocore positions in Q3 2025 and 18 closed out, a net change of 0 holders.
- The largest Immunocore buyer in Q3 2025 was Millennium Management, an estimated $33.6M added.
- The largest Immunocore seller in Q3 2025 was Fidelity Investments, an estimated $14.8M sold.
Based on aggregated 13F filings for Q3 2025.